This section is not available in the published analysis.
VLN® Reduced Nicotine Content Cigarettes: Audience
22nd Century Group, Inc. is a biotechnology company that focuses on improving human health through plant science, specifically by developing reduced nicotine content tobacco products. Their flagship product, VLN®, contains 95% less nicotine than conventional cigarettes, aiming to assist smokers in reducing their intake.